The North America coenzyme Q10 market size exceeded USD 290 million in 2019 and is estimated to register substantial gains at over 10% up to 2026 driven by growing consumer awareness regarding skin care and health benefits of nutraceuticals and supplements. 

North America Coenzyme Q10 Market Size & Share | Forecasts 2026

North America Coenzyme Q10 Market Size By Application (Pharmaceuticals, Dietary Supplements, Cosmetics), Research Report, Country Outlook, Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2020 - 2026

Report Content

Chapter 1&nbsp;&nbsp;&nbsp;Methodology &amp; Scope

1.1&nbsp;&nbsp;&nbsp; Market definitions

1.2&nbsp;&nbsp;&nbsp; Market assumptions &amp; forecast parameters

1.3&nbsp;&nbsp;&nbsp; Appendix

1.4&nbsp;&nbsp;&nbsp; Data Sources

1.4.1&nbsp;&nbsp;&nbsp; Primary

1.4.2&nbsp;&nbsp;&nbsp; Secondary

Chapter 2&nbsp;&nbsp;&nbsp;Executive Summary

2.1&nbsp;&nbsp;&nbsp; North America Coenzyme Q10 industry summary, 2015 - 2026

2.1.1&nbsp;&nbsp;&nbsp; Business trends

2.1.2&nbsp;&nbsp;&nbsp; Application trends

2.1.3&nbsp;&nbsp;&nbsp; Country trends

Chapter 3&nbsp;&nbsp;&nbsp;North America Coenzyme Q

3.1&nbsp;&nbsp;&nbsp; Industry segmentation

3.2&nbsp;&nbsp;&nbsp; Industry outlook, 2015 - 2026

3.3&nbsp;&nbsp;&nbsp; Value Chain

3.4&nbsp;&nbsp;&nbsp; Regulatory overview

3.5&nbsp;&nbsp;&nbsp; Market factor analysis

3.5.1&nbsp;&nbsp;&nbsp; Growth drivers

3.5.2&nbsp;&nbsp;&nbsp; Growth restraints

3.6&nbsp;&nbsp;&nbsp; Competition review

3.7&nbsp;&nbsp;&nbsp; Porter&rsquo;s analysis

3.8&nbsp;&nbsp;&nbsp; PESTEL analysis

3.9&nbsp;&nbsp;&nbsp; Impact of COVID-19 on CoQ10 demand by application

Chapter 4&nbsp;&nbsp;&nbsp;North America Coenzyme Q

4.1&nbsp;&nbsp;&nbsp; Market trends

4.2&nbsp;&nbsp;&nbsp; Pharmaceuticals

4.2.1&nbsp;&nbsp;&nbsp; Market size from Pharmaceuticals applications, 2015-2026, (Tons) (USD Million)

4.2.2&nbsp;&nbsp;&nbsp; Market size from Pharmaceuticals applications, by country, 2015-2026, (Tons) (USD Million)

4.3&nbsp;&nbsp;&nbsp; Dietary Supplements

4.3.1&nbsp;&nbsp;&nbsp; Market size from Dietary Supplements, 2015-2026, (Tons) (USD Million)

4.3.2&nbsp;&nbsp;&nbsp; Market size from Dietary Supplements, by country, 2015-2026, (Tons) (USD Million)

4.4&nbsp;&nbsp;&nbsp; Cosmetics

4.4.1&nbsp;&nbsp;&nbsp; Market size from Cosmetics, 2015-2026, (Tons) (USD Million)

4.4.2&nbsp;&nbsp;&nbsp; Market size from Cosmetics, by country, 2015-2026, (Tons) (USD Million)

Chapter 5&nbsp;&nbsp;&nbsp;North America Coenzyme Q

5.1&nbsp;&nbsp;&nbsp; Major trends

5.2&nbsp;&nbsp;&nbsp; U.S.

5.2.1&nbsp;&nbsp;&nbsp; U.S. coenzyme Q10 market, 2015-2026, (Tons) (USD Million)

5.2.2&nbsp;&nbsp;&nbsp; U.S. coenzyme Q10 market, by application, 2015-2026, (Tons) (USD Million)

5.3&nbsp;&nbsp;&nbsp; Canada

5.3.1&nbsp;&nbsp;&nbsp; Canada coenzyme Q10 market, 2015-2026, (Tons) (USD Million)

5.3.2&nbsp;&nbsp;&nbsp; Canada coenzyme Q10 market, by application, 2015-2026, (Tons) (USD Million)

5.4&nbsp;&nbsp;&nbsp; Mexico

5.4.1&nbsp;&nbsp;&nbsp; Mexico coenzyme Q10 market, 2015-2026, (Tons) (USD Million)

5.4.2&nbsp;&nbsp;&nbsp; Mexico coenzyme Q10 market, by application, 2015-2026, (Tons) (USD Million)

Chapter 6&nbsp;&nbsp;&nbsp;Company Profiles

7.1&nbsp;&nbsp;&nbsp; Kaneka Corporation

6.1.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.1.2&nbsp;&nbsp;&nbsp; Financial Information

6.1.3&nbsp;&nbsp;&nbsp; Product Offerings

6.1.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.2&nbsp;&nbsp;&nbsp; Healthy Origins

6.2.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.2.2&nbsp;&nbsp;&nbsp; Financial Information

6.2.3&nbsp;&nbsp;&nbsp; Product Offerings

6.2.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.3&nbsp;&nbsp;&nbsp; DSM

6.3.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.3.2&nbsp;&nbsp;&nbsp; Financial Information

6.3.3&nbsp;&nbsp;&nbsp; Product Offerings

6.3.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.4&nbsp;&nbsp;&nbsp; NBTY

6.4.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.4.2&nbsp;&nbsp;&nbsp; Financial Information

6.4.3&nbsp;&nbsp;&nbsp; Product Offerings

6.4.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.5&nbsp;&nbsp;&nbsp; NOW Foods

6.5.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.5.2&nbsp;&nbsp;&nbsp; Financial Information

6.5.3&nbsp;&nbsp;&nbsp; Product Offerings

6.5.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.6&nbsp;&nbsp;&nbsp; Natural Organics

6.6.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.6.2&nbsp;&nbsp;&nbsp; Financial Information

6.6.3&nbsp;&nbsp;&nbsp; Product Offerings

6.6.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.7&nbsp;&nbsp;&nbsp; Tishcon Corp.

6.7.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.7.2&nbsp;&nbsp;&nbsp; Financial Information

6.7.3&nbsp;&nbsp;&nbsp; Product Offerings

6.7.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.8&nbsp;&nbsp;&nbsp; Novartis

6.8.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.8.2&nbsp;&nbsp;&nbsp; Financial Information

6.8.3&nbsp;&nbsp;&nbsp; Product Offerings

6.8.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.9&nbsp;&nbsp;&nbsp; GlaxoSmithKline

6.9.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.9.2&nbsp;&nbsp;&nbsp; Financial Information

6.9.3&nbsp;&nbsp;&nbsp; Product Offerings

6.9.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.10&nbsp;&nbsp;&nbsp; Johnson &amp; Johnson

6.10.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.10.2&nbsp;&nbsp;&nbsp; Financial Information

6.10.3&nbsp;&nbsp;&nbsp; Product Offerings

6.10.4&nbsp;&nbsp;&nbsp; Strategic Outlook

6.11&nbsp;&nbsp;&nbsp; Pfizer

6.11.1&nbsp;&nbsp;&nbsp; Business Snapshot

6.11.2&nbsp;&nbsp;&nbsp; Financial Information

6.11.3&nbsp;&nbsp;&nbsp; Product Offerings

6.11.4&nbsp;&nbsp;&nbsp; Strategic Outlook 
&nbsp;